

Is amphetamine/dextroamphetamine IR still in shortage in 2026? Get the latest update on availability, pricing, and what you can do to find your medication.
If you take amphetamine/dextroamphetamine IR (generic Adderall) for ADHD or narcolepsy, the past three-plus years have been exhausting. What started as a supply disruption in late 2022 has turned into one of the longest-running prescription drug shortages in the United States.
In this update, we'll cover where things stand in early 2026, why the shortage continues, what it's costing patients, and what you can do about it.
Yes — but it's complicated.
The FDA first listed amphetamine mixed salts as in shortage in October 2022, after Teva Pharmaceutical Industries (the largest generic manufacturer) reported manufacturing delays. The shortage peaked in 2023, when patients across the country reported going weeks or even months without their medication.
Since then, supply has gradually improved. The DEA increased the aggregate production quota (APQ) for d-amphetamine by 25% in October 2025, raising it from 21.2 million grams to 26.5 million grams. The DEA also set 2026 quotas in January 2026 that account for higher demand.
However, intermittent regional shortages continue. Some pharmacies have consistent stock while others — sometimes in the same city — can't get any. The situation varies by:
The shortage is driven by a combination of factors that haven't fully resolved:
ADHD diagnoses and stimulant prescriptions have increased significantly, driven in part by expanded telehealth access during and after the COVID-19 pandemic. More patients need the medication than ever before.
Even with increased DEA quotas, manufacturers need time to scale up. Building additional production capacity for a Schedule II controlled substance involves regulatory approvals, raw material sourcing, and quality control processes that can take months.
Drug distributors place allocation limits on controlled substances, restricting how much any single pharmacy can order. Even when national supply is adequate, local distribution can create gaps. For more on why this medication is so hard to find, see our detailed explainer.
Cost varies significantly depending on whether you have insurance, which pharmacy you use, and whether you use discount coupons:
The generic version is significantly cheaper and therapeutically equivalent. If you're paying more than $50 out of pocket, you may be able to save with a discount card. See our full guide: How to save money on amphetamine/dextroamphetamine IR.
While no entirely new amphetamine IR products have launched recently, the market for ADHD medications has expanded:
Talk to your doctor about whether any of these options might work for you. Our alternatives guide compares the most common options.
Here's what's working for patients right now:
For a deeper dive into finding strategies, read our full guide: How to find amphetamine/dextroamphetamine IR in stock near you.
The amphetamine/dextroamphetamine IR shortage is improving — but slowly. If you depend on this medication, you'll likely still need to plan ahead and be resourceful in 2026.
The most important things you can do: use tools like Medfinder to check availability, work closely with your doctor, and don't wait until you're completely out to start looking for a refill.
This shortage has affected real people in real ways — missed work, struggling grades, disrupted daily life. You deserve better, and the supply situation is getting better. Hang in there.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.